These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10527675)

  • 41. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
    Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
    Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A length polymorphism in an intron of the canine polycystic kidney disease 1 gene.
    Liu PC; Chen YW; Shibuya H; Lubahn DB; Johnson GS
    Anim Genet; 1998 Aug; 29(4):322-3. PubMed ID: 9745674
    [No Abstract]   [Full Text] [Related]  

  • 43. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
    Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PKDB: Polycystic Kidney Disease Mutation Database--a gene variant database for autosomal dominant polycystic kidney disease.
    Gout AM; Martin NC; Brown AF; Ravine D
    Hum Mutat; 2007 Jul; 28(7):654-9. PubMed ID: 17370309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.
    Piontek KB; Huso DL; Grinberg A; Liu L; Bedja D; Zhao H; Gabrielson K; Qian F; Mei C; Westphal H; Germino GG
    J Am Soc Nephrol; 2004 Dec; 15(12):3035-43. PubMed ID: 15579506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four novel mutations of the PKD2 gene in Czech families with autosomal dominant polycystic kidney disease.
    Reiterová J; Stekrová J; Peters DJ; Kapras J; Kohoutová M; Merta M; Zidovská J
    Hum Mutat; 2002 May; 19(5):573. PubMed ID: 11968093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
    Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
    Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathophysiology of autosomal dominant polycystic kidney disease].
    Rózański J; Domański L; Myślak M; Ciechanowski K; Szmatłoch E
    Pol Arch Med Wewn; 2000 Aug; 104(2):519-23. PubMed ID: 11303320
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease].
    Joly D
    Med Sci (Paris); 2011 Mar; 27(3):249-51. PubMed ID: 21447293
    [No Abstract]   [Full Text] [Related]  

  • 51. Predictions for polycystin.
    Nat Genet; 1995 Jun; 10(2):123-4. PubMed ID: 7663502
    [No Abstract]   [Full Text] [Related]  

  • 52. Prime suspect for cystic kidneys.
    Nat Genet; 1994 Jul; 7(3):341-2. PubMed ID: 7920647
    [No Abstract]   [Full Text] [Related]  

  • 53. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes.
    Lu W; Fan X; Basora N; Babakhanlou H; Law T; Rifai N; Harris PC; Perez-Atayde AR; Rennke HG; Zhou J
    Nat Genet; 1999 Feb; 21(2):160-1. PubMed ID: 9988265
    [No Abstract]   [Full Text] [Related]  

  • 54. Cystic changes of breast in a family with autosomal dominant polycystic kidney disease.
    Maleki D; Ghafari A
    Iran J Kidney Dis; 2009 Oct; 3(4):246-8. PubMed ID: 19841531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular basis of renal cyst formation--one hit or two?
    Ong AC; Harris PC
    Lancet; 1997 Apr; 349(9058):1039-40. PubMed ID: 9107237
    [No Abstract]   [Full Text] [Related]  

  • 56. Cystic kidney diseases.
    Griffin MD; Torres VE; Kumar R
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):276-83. PubMed ID: 9263671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recent advances in studies on autosomal dominant adult polycystic kidney disease].
    Yu CW; Zhang SZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):402-5. PubMed ID: 20677145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in molecular genetics of autosomal dominant polycystic kidney disease.
    Trudel M; Guillaume R
    Front Biosci; 2000 Mar; 5():D312-20. PubMed ID: 10704432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis in cystogenesis: hands on or hands off?
    Torres VE
    Kidney Int; 1999 Jan; 55(1):334-5. PubMed ID: 9893145
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyst formation in ADPKD: new insights from natural and targeted mutants.
    Ong AC
    Nephrol Dial Transplant; 1999 Mar; 14(3):544-6. PubMed ID: 10193792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.